- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02022176
Modulation of Metabolic Rate by Inorganic Nitrate
January 2, 2014 updated by: Eddie Weitzberg, Karolinska Institutet
Dietary Inorganic Nitrate: Effects on Metabolic Rate, Reactive Oxygen Species Production, Glucose Uptake and Primary Myotube Respiration.
The purpose of this study is to determine the effects of sodium nitrate on resting metabolic rate, glucose uptake and formation of reactive oxygen species in humans.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
55
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Stockholm, Sweden, 17177
- Karolinska Institutet
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
Healthy volunteers
Exclusion Criteria Chronic medication Vegetarian Nicotine Users Known metabolic disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Sodium nitrate
0.1 mmol NaNO3 / kg bodyweight / day for three days.
|
Glucose uptake is measured by oral glucose tolerance test and euglycemic clamp
Resting metabolic rate is measured by indirect calorimetry after an over-night fast
|
Placebo Comparator: Sodium Chloride
0.1 mmol NaCl / kg bodyweight / day for three days.
|
Glucose uptake is measured by oral glucose tolerance test and euglycemic clamp
Resting metabolic rate is measured by indirect calorimetry after an over-night fast
|
Active Comparator: Sodium nitrite infusion
Sodium nitrite (NaNO2) at a rate of 1, 10 and 100 nmol kg-1 min-1 (10 minutes per dose) was infused intravenously.
|
Sodium nitrite or saline was infused at escalating doses at a rate of 1, 10 or 100 nmol kg-1 min-1 (10 minutes per dose) in a randomized, double blinded cross-over fashion
|
Placebo Comparator: Saline infusion
Saline at a rate corresponding to 1, 10 and 100 nmol NaCl kg-1 min-1 (10 minutes per dose) was infused intravenously.
|
Sodium nitrite or saline was infused at escalating doses at a rate of 1, 10 or 100 nmol kg-1 min-1 (10 minutes per dose) in a randomized, double blinded cross-over fashion
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Resting metabolic rate
Time Frame: day 4
|
Resting metabolic rate, measured after overnight fast using indirect calorimetry
|
day 4
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Thyroid hormone status
Time Frame: day 4
|
day 4
|
|
Glucose uptake
Time Frame: day 4
|
Glucose uptake measured with oral glucose tolerance test and euglycemic clamp
|
day 4
|
Nitrite infusion
Time Frame: 30 minutes
|
Effect on resting metabolic rate when infusing escalating intravenous doses of sodium nitrite or saline solution
|
30 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2008
Primary Completion (Actual)
September 1, 2013
Study Completion (Actual)
September 1, 2013
Study Registration Dates
First Submitted
December 16, 2013
First Submitted That Met QC Criteria
December 20, 2013
First Posted (Estimate)
December 27, 2013
Study Record Updates
Last Update Posted (Estimate)
January 3, 2014
Last Update Submitted That Met QC Criteria
January 2, 2014
Last Verified
January 1, 2014
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- JETF-6996-NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Resting Metabolic Rate
-
Pennington Biomedical Research CenterWeight Watchers InternationalCompletedResting Metabolic RateUnited States
-
MicrolifeCompletedResting Metabolic RateUnited States
-
Florida State UniversityCompletedHeart Rate Variability | Appetite | Resting Metabolic RateUnited States
-
University of ThessalyCompletedBody Composition | Physical Fitness | Energy Expenditure | Resting Metabolic RateGreece
-
University of ThessalyCompletedBody Composition | Physical Fitness | Energy Expenditure | Resting Metabolic RateGreece
-
AmgenWithdrawnHeart Transplantation, Elevated Resting Heart Rate
-
Iberoamerican Institute of Sports Science and Human...CompletedAthletic Injuries | Disability Physical | Resting Metabolic RateMexico
-
USDA Grand Forks Human Nutrition Research CenterCompleted
-
University of ThessalyCompletedBody Composition | Physical Fitness | Energy Expenditure | Resting Metabolic RateGreece
-
University of Kansas Medical CenterNot yet recruitingResting Metabolic Rate | Post Operative Nutrition | Metabolism; Disorder, Postprocedural
Clinical Trials on Glucose Uptake
-
University of Texas Southwestern Medical CenterCompletedSarcoma | Neuroblastoma | Pediatric CancerUnited States
-
University Hospital, MontpellierRecruitingAneurysmal Subarachnoid HaemorrhageFrance
-
Children's Mercy Hospital Kansas CityWithdrawnType 1 DiabetesUnited States
-
University of Massachusetts, WorcesterNot yet recruitingPregnancy, High Risk | Type 2 Diabetes Treated With InsulinUnited States
-
Glostrup University Hospital, CopenhagenUnknown
-
Makassed General HospitalCompleted
-
US Department of Veterans AffairsEmory UniversityCompletedType 2 Diabetes Mellitus | Prediabetic StateUnited States
-
NestléCompletedHealthyNew Zealand